Antihyperalgesic effects of spinal cannabinoids
- 1 March 1998
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 345 (2) , 145-153
- https://doi.org/10.1016/s0014-2999(97)01621-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated miceEuropean Journal of Pharmacology, 1997
- Suppression of noxious stimulus-evoked expression of fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonistNeuroscience, 1996
- Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2Life Sciences, 1995
- Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytesNeuroscience Letters, 1995
- Alterations in neuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenan-induced inflammationPain, 1992
- Cannabinoid receptor agonists inhibit Ca current in NG108–15 neuroblastoma cells via a Pertussis toxin‐sensitive mechanismBritish Journal of Pharmacology, 1992
- Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanismsEuropean Journal of Pharmacology, 1991
- Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesiaPain, 1990
- Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compoundsLife Sciences, 1984
- Intrathecal morphine in mice: A new techniqueEuropean Journal of Pharmacology, 1980